1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TXNDC16 CTRPv2 pan-cancer AAC 0.19 9e-09
mRNA SALL2 CTRPv2 pan-cancer AAC 0.2 9e-09
mRNA SHPRH CTRPv2 pan-cancer AAC 0.21 1e-08
mRNA UBTF CTRPv2 pan-cancer AAC 0.21 1e-08
mRNA ZNF292 CTRPv2 pan-cancer AAC 0.19 1e-08
mRNA ZNF8 CTRPv2 pan-cancer AAC 0.21 1e-08
mRNA WTAP CTRPv2 pan-cancer AAC 0.19 1e-08
mRNA PHF14 CTRPv2 pan-cancer AAC 0.19 1e-08
mRNA ZNF236 CTRPv2 pan-cancer AAC 0.19 1e-08
mRNA SCAF8 CTRPv2 pan-cancer AAC 0.19 1e-08
Download CSV